EUVIMEDEUVIMED entdecken
KohortenstudieOpen Access · CC BY 4.0

Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study

Perrine Roux iD, Aissatou Faye, Luis Sagaon-Teyssier, Cécile Donadille, Laélia Briand Madrid, Maria Patrizia Carrieri, Gwenaelle Maradan, Marie Jauffret-Roustide iD, Laurence Lalanne, Marc Auriacombe iD, COSINUS study group

Drug and Alcohol Review · 2025

DOI: 10.1111/dar.13955 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Drug and Alcohol Review, 2025. Verfasst von Perrine Roux und 10 weiteren Autor:innen. Beteiligte Einrichtung: Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, Fran…. Hauptthemen laut MEDLINE: Substance Abuse, Intravenous, Opioid-Related Disorders, Opiate Substitution Treatment, Analgesics, Opioid. Die Arbeit nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: French Government Addiction Agency MILDECA (The inter-ministerial mission to fight against drugs and addictive practices).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

The co‐use of stimulants and opioids, including opioid agonist treatment (OAT), is very prevalent worldwide. A large body of data exists on the association between stimulant use and its health complications, and on OAT effectiveness among people with opioid use disorder. However, few data exist on stimulant‐opioid co‐use among people receiving OAT. Using data from the COSINUS cohort study, we investigated the association between the type of OAT and problematic stimulant use among persons who inject drugs (PWID).

Methods

COSINUS is a 12‐month French cohort study of 665 PWID. Data were collected in face‐to‐face interviews at enrolment, at 6 and 12 months. We defined problematic stimulant use as daily use of and/or injecting stimulants. We used Bayesian model averaging (BMA) to identify factors associated with problematic stimulant use.

Results

At baseline, 76% ( n = 505) of the participants reported problematic stimulant use. The optimal model from the BMA estimation showed that, after adjusting on social precarity and daily injection, participants on prescribed morphine sulfate as an OAT (compared with methadone) and those who use daily unprescribed buprenorphine were less likely to report problematic stimulant use. Discussion and Conclusions Our work highlights the high prevalence of problematic stimulant use among PWID in France but also the potential association between the type of OAT taken and stimulant use, by suggesting a protective effect of morphine sulfate on stimulant use. Since it has a higher intrinsic activity than other opioids, PWID on this OAT may be less interested in stimulants. Our findings warrant further investigation in clinical studies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Substance Abuse, IntravenousOpioid-Related DisordersOpiate Substitution TreatmentAnalgesics, OpioidCentral Nervous System StimulantsHumansFranceMaleFemaleAdultPrevalenceCohort StudiesMiddle AgedBuprenorphineMethadone

Stichwörter der Autor:innen

morphineopioid agonist treatmentproblematic usestimulantssubstitution

Substanzen

Analgesics, OpioidCentral Nervous System StimulantsBuprenorphineMethadone

Autor:innen und Institutionen

  • Aix Marseille Univ, Inserm, IRD, SESSTIM, Sciences Economiques & Sociales de la Santé & Traitement de l'Information Médicale, ISSPAM, Marseille, France.
  • ORS PACA, Observatoire régional de la santé Provence-Alpes-Côte d'Azur, Marseille, France.
  • Centre d'étude des mouvements sociaux (Inserm U1276/UMR CNRS 8044/EHESS/Paris), Paris, France.
  • British Columbia Center on Substance Use, Vancouver, Canada.
  • Baldy Center on Law and Social Policy, Buffalo University, New York, USA.
  • Institut Universitaire sur les Dépendances, Montréal, Canada.

ORCID-Profile: Perrine Roux, Marie Jauffret-Roustide, Marc Auriacombe

Förderung

  • French Government Addiction Agency MILDECA (The inter-ministerial mission to fight against drugs and addictive practices)

Zitieren

APA

Roux, P., Faye, A., Sagaon-Teyssier, L., Donadille, C., Briand Madrid, L., Carrieri, M. P., Maradan, G., Jauffret-Roustide, M., Lalanne, L., Auriacombe, M., & COSINUS study group (2025). Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study. Drug and Alcohol Review. https://doi.org/10.1111/dar.13955

Vancouver

Roux P, Faye A, Sagaon-Teyssier L, Donadille C, Briand Madrid L, Carrieri MP, et al. Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study. Drug and Alcohol Review. 2025. doi:10.1111/dar.13955

BibTeX
@article{Roux2025,
  author = {Roux, Perrine and Faye, Aissatou and Sagaon-Teyssier, Luis and Donadille, Cécile and Briand Madrid, Laélia and Carrieri, Maria Patrizia and Maradan, Gwenaelle and Jauffret-Roustide, Marie and Lalanne, Laurence and Auriacombe, Marc and COSINUS study group, COSINUS study group},
  title = {Prevalence of stimulant use and the role of opioid agonist treatment among people who inject drugs in France: Results from the COSINUS cohort study},
  journal = {Drug and Alcohol Review},
  year = {2025},
  doi = {10.1111/dar.13955}
}
Kostenlos starten →